期刊文献+

正性调节区锌指蛋白14的研究进展 被引量:2

Research Progress of PR Domain Zinc Finger Protein 14
下载PDF
导出
摘要 正性调节区锌指蛋白14(PR domain zinc finger protein 14,PRDM14)是PRDM家族中的重要成员,PRDM14基因对维持细胞的完整性和控制细胞的分化、生长及凋亡起着关键作用,在原始生殖细胞的形成、干细胞全能性的维持和其他组织器官的形成中都发挥了重要作用。PRDM14具有1个PR结构域和6个锌指结构,PRDM14参与了组蛋白的去乙酰化及甲基化过程,通过启动子区甲基化水平的改变参与肿瘤的形成。PRDM14异常甲基化能够引起染色质结构、DNA构象及DNA与蛋白质作用方式的改变,使基因的转录和表达受抑制,这些改变引起了肿瘤的发生、发展及转移。本文根据国内外发表的相关文献对PRDM14的研究现状进行综述。 PR domain zinc finger protein 14 (PRDM14) is an important member of the PRDM family, PRDM14 plays a key role in the maintenance of cell integrity and differentiation, growth and apoptosis of the cell. It also plays an critical role in the formation of primordial germ cells, the maintenance of the totipotency of stem cells and the formation of tissues and organs. PRDM14 bears a single PR domain and six tandemly repeated zinc fingers, which is involved in the process of the deacetylation and methylation of the histone, and is involved in the formation of tumor trough the change level of methylation in the promoter region. ~he abnormal methylation of PRDM14 can change the chromatin structure, DNA conformation and the interaction mode of DNA and protein, it can suppress transcription and expression of the gene, which caused the occur- rence, development and metastasis of tumor. The research progress of PRDM14 is reviewed based on the relevant literatures published in China and abroad.
作者 韩玉栋 林强
出处 《中国肺癌杂志》 CAS CSCD 北大核心 2016年第2期93-97,共5页 Chinese Journal of Lung Cancer
基金 国家自然科学基金面上项目(No.81372521)资助~~
关键词 PRDM14 表观遗传学 肿瘤 PRDM14 Epigenetic Neoplasm
  • 相关文献

参考文献3

二级参考文献119

  • 1梅新宇,孙余婕,徐美青,马冬春,魏大中,田界勇,任自学.非小细胞肺癌3p染色体多区域杂合性缺失检测的研究[J].中国肺癌杂志,2008,11(4):534-537. 被引量:3
  • 2MINGShu-hong,SUNTie-ying,XIAOWei,XUXiao-mao.Matrix metalloproteinases-2,-9 and tissue inhibitor of metallo-proteinase-1 in lung cancer invasion and metastasis[J].Chinese Medical Journal,2005(1):69-72. 被引量:14
  • 3Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene, 2002, 21 (45): 6915-6935.
  • 4Anglim PP, Alonzo TA, Laird-Offringa IA. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer, 2008, 7:81.
  • 5Daigo Y, Nishiwaki T, Kawasoe T, et al. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res, 1999, 59(8): 1966-1972.
  • 6Qiu GH, Salto-Tellez M, Ross JA, et al. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatoceUular carcinoma and induces G, arrest in cell cycle. J Hepatol, 2008, 48(3): 433-441.
  • 7Wang Y, Yu Z, Wang T, et al. Identification of epigenetic aberrant promoter methylation of RASSFIA in serum DNA and its clinicopathological significance in lung cancer. Lung Cancer, 2007, 56(2): 289-294.
  • 8Tomizawa Y, lijima H, Nomoto T, et al. Clinicopathological significance ofaberrant methylation of RARbeta2 at 3p24, RASSFIA at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer. Lung Cancer, 2004, 46(3): 305-312.
  • 9Geng X, Wang F, Zhang L, et al. Loss of heterozygosity combined with promoter hypermethylation, the main mechanism of human MutL Homolog (hMLH1) gene inactivation in non-small cell lung cancer in a Chinese population. Tumori, 2009, 95 (4): 488-494.
  • 10Verri C, Roz L, Conte D, et al. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. Am J Respir Crit Care Med, 2009, 179(5): 396-401.

共引文献31

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部